By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    health benefits of taking a vacation to reduce stress
    Relaxing European Destinations to Reduce Stress Risks to Health
    October 11, 2021
    pain management tips
    Managing Pain Differently: Alternative Pain Management Techniques
    January 12, 2022
    5 Ways to Promote Wellness in Your Home
    April 12, 2022
    Latest News
    Clean Your Mattress Properly to Avoid Common Health Issues
    March 29, 2023
    5 Benefits Of HIPAA-Compliant Answering Services
    March 28, 2023
    3 Ways To Deal With Health Issues In Cities With High Pollution
    March 22, 2023
    What Tools Should Your Caregiver Have?
    March 22, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    What We Have to Be Thankful For
    November 24, 2011
    Thermalin Diabetes Follows the “Coulter Process” And Addresses Significant Needs in the Insulin Market
    December 27, 2011
    Will Power is Biological
    January 14, 2012
    Latest News
    What Are Bioidentical Hormones Made With?
    March 23, 2023
    Cover Medical Costs of Child Dog Bites with Legal Specialists
    March 23, 2023
    3 Ways to Improve the U.S. Healthcare System By 2030
    March 14, 2023
    6 Steps To Ensure Speed And Efficiency Of Clinical Studies
    March 14, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Cancer Patient’s Compassionate Use Conundrum Leads to Social Media Ambush on BioMarin
Share
Sign In
Notification Show More
Latest News
healthy travel tips when visiting Australia
7 Essential Tips to Stay Safe and Healthy Visiting Australia
News
health risks of dirty mattress
Clean Your Mattress Properly to Avoid Common Health Issues
Health
eligble for NDIS?
Are You Eligible For NDIS? How To Apply
News
upgrade to your nursing career
4 Pertinent Ways to Upgrade Your Nursing Career
Nursing
career in nursing
8 Keys to A Fulfilling & Successful Career in Nursing
Career
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > eHealth > Social Media > Cancer Patient’s Compassionate Use Conundrum Leads to Social Media Ambush on BioMarin
BusinesseHealthNewsSocial Media

Cancer Patient’s Compassionate Use Conundrum Leads to Social Media Ambush on BioMarin

Deanna Pogorelc
Last updated: 2013/09/25 at 8:11 AM
Deanna Pogorelc
Share
4 Min Read
compassionate use
SHARE

compassionate use

Originally published on MedCityNews.com.

compassionate use

Originally published on MedCityNews.com.

More Read

hair transplants for cancer patients

Why Reputable Hair Transplant Clinics Can Help Cancer Patients

How to Combat Home Sickness After Moving Abroad
The Health and Legal Risks of Living in Your Vehicle
Nutrition Advice: Cut Back on Added Sugar (+ Save Money)
The Everest Foundation’s Mission to Support Inclusive Healthcare

For the past seven years, Andrea Sloan has been battling ovarian cancer. Now, she’s waging a second battle – this one against BioMarin Pharmaceuticals (NASDAQ:BMRN) – after being denied access to an experimental drug she thinks is her last hope. And in the process, she’s raising some tough questions about the process of clinical trials and drug approvals.

Thanks to Twitter, Facebook and mainstream media, Sloan has collected some 147,000 signatures on a petition to the CEO of the San Rafael, California, pharmaceutical company. She’s requesting access to BMN673, BioMarin’s cancer drug which shrunk the tumors of 11 out of 25 ovarian cancer patients by at least 30 percent in a recent Phase 1/2 trial,

Those might not seem like great odds, but 45-year-old Sloan and her doctors think it’s her last chance at survival. Since being diagnosed with stage 3 ovarian cancer seven years ago, she’s been through several rounds of chemotherapy, two rounds of radiation and five surgeries. Even after she was in remission for a few years, the cancer returned.

Unable to operate on her anymore, Dr. Charles Levenback at the MD Anderson Cancer Center suggested she look for alternative options — namely, BioMarin’s drug. The problem is that BioMarin, at least for now, is conducting a Phase 3 trial of the drug in breast cancer patients, not ovarian cancer patients.

The FDA allows drug companies to give experimental drugs to patients outside of clinical trials if a patient has a life-threatening disease and has “no comparable or satisfactory alternative treatment options.” Sloan meets those “compassionate use” requirements and was cleared by the FDA to pursue access to the drug, given that she has waived any responsibility on the part of BioMarin if the it doesn’t work or, worse, does more harm. But the company has turned down her request in a written letter, saying it’s “too early to know if the experimental therapy is safe or effective, or will even prolong life.”

A lawyer by training and the executive director of Texas Advocacy Project, a non-profit that provides free legal services to victims of domestic violence and sexual assault, Sloan isn’t one to quietly accept no for an answer. She’s amassed an “Andi’s Army” of nearly 13,000 people on Facebook, started a conversation with the Twitter hashtag #BMN673 and gained the support of celebrities including Newt Gingrich, who wrote about her in a blog post titled A Sick Bureaucracy.

BioMarin, for its part, hasn’t said much. In a letter Sloan provided to Huffington Post, Chief Medical Officer, Henry Fuchs, wrote that the company was evaluating whether to conduct additional trials in ovarian cancer but hadn’t reached a decision yet.

At the heart of Sloan’s social media ambush is, of course, the desire to save her own life. But in an interview with Huffington Post Live, she said her goal wasn’t to encourage tons of grassroots campaigns like her own by all of the other patients in her same position who can’t get access to potentially life-saving drugs. Rather, she said, the goal is to encourage companies to “develop meaningful policies that are easily navigable by patients and their physicians in extreme circumstances.”

[Photo from change.org]

TAGGED: Andrea Sloan, BioMarin Pharmaceuticals

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Deanna Pogorelc September 25, 2013
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article What Causes Dementia? New Research Findings Point to Unexpected Factors
Next Article Medulous logo New Website Helps Patients Avoid Bad Medical Treatments

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

healthy travel tips when visiting Australia
7 Essential Tips to Stay Safe and Healthy Visiting Australia
News March 29, 2023
health risks of dirty mattress
Clean Your Mattress Properly to Avoid Common Health Issues
Health March 29, 2023
eligble for NDIS?
Are You Eligible For NDIS? How To Apply
News March 29, 2023
upgrade to your nursing career
4 Pertinent Ways to Upgrade Your Nursing Career
Nursing March 29, 2023

You Might also Like

healthy travel tips when visiting Australia
News

7 Essential Tips to Stay Safe and Healthy Visiting Australia

March 29, 2023
eligble for NDIS?
News

Are You Eligible For NDIS? How To Apply

March 29, 2023
CPR classes
News

What Are the Different Levels of CPR Training?

March 29, 2023
relation between Trauma and Chronic Pain
NewsWellness

Understanding the Relationship Between Trauma and Chronic Pain

March 28, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?